Psychopharmacology and Psychiatry Updates Lurasidone: Managing Bipolar Depression with Comorbid Anxiety
Jan 26, 2026
Kristin Raj, psychiatrist and clinical educator specializing in psychopharmacology and mood disorders. She discusses lurasidone at low doses for bipolar I depression with comorbid anxiety. Short doses (20–60 mg/day) may improve both mood and anxiety and show favorable metabolic and tolerability profiles. Practical dosing advice and reasons why higher doses might be less helpful are explored.
AI Snips
Chapters
Transcript
Episode notes
Patient Case Framing The Problem
- A 38-year-old woman with bipolar I depression presented mainly distressed by relentless anxiety and panic attacks.
- This case framed the clinical dilemma of treating anxiety when SSRIs risk mood destabilization.
Anxiety Is Common And Clinically Important
- Anxiety affects roughly 40–50% of people with bipolar disorder and worsens outcomes like suicide risk and treatment response.
- The DSM-5 now includes anxious distress as a specifier for bipolar depression, highlighting its clinical importance.
Guidelines Prioritize Mood Stabilization
- CANMAT and ISBD advise prioritizing mood stabilization before targeting anxiety symptoms.
- Evidence-based anxiety treatments in bipolar depression remain limited, prompting exploration of alternatives.